Table 1.
Correlation between FTO expression and clinicopathological characteristics of 67 bladder cancer patients.
| Parameters | Number of cases | FTO expressiona | P Value | |
|---|---|---|---|---|
| Low | High | |||
| All cases | 67 | 23 | 44 | |
| Age(years) | ||||
| <65 | 24 | 8 | 16 | 0.995 |
| ≥65 | 43 | 15 | 28 | |
| Gender | ||||
| Male | 57 | 20 | 37 | 0.755 |
| Female | 10 | 3 | 7 | |
| TNM stage | ||||
| pTa-pT1 | 21 | 11 | 10 | 0.035* |
| pT2-pT4 | 46 | 12 | 34 | |
| Histological grade | ||||
| Low | 9 | 5 | 4 | 0.14 |
| high | 58 | 18 | 40 | |
*Statistically significant, P < 0.05
aOn the basis of the IHC scores, the patients were divided into low (0–3) and high (4–9) FTO groups. Final IHC score = percentage of positive cells × intensity score.